Выпуск
Pharmaceutical Executive Daily: FDA Approves New Indication for Kerendia
Pharmaceutical Executive · 17 сентября 2026 г. · 3 мин
FDA approves Kerendia as the first new treatment for kidney disease in type 1 diabetes in decades, Novo, Roche, and Aethlon Medical strike major deals and mergers with Orbis Medicines, Dualitas Therapeutics, and North Immunology, and Thani Jambulingam of Saint Joseph's University examines the fight to control the GLP-1 patient journey.